Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis

Mycophenolate mofetil in the treatment of systemic lupus erythematosus

(2011) Maria Dall’Era   CURRENT OPINION IN RHEUMATOLOGY

Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis

(2011) X. Li et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial

(2010) Wei Chen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

(2010) F. A. Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis

(2010) Hiroshi Tanaka et al.   CLINICAL RHEUMATOLOGY

Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis

(2010) CM Lanata et al.   LUPUS

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy

(2008) H. Bao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY